Photo Credit: Flik47

The following is a summary of “Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma,” published in the November 2023  issue of Dermatology by Huang, et al.

Infiltrative basal cell carcinoma (iBCC) is a very aggressive type of basal cell carcinoma. It tends to get worse and come back after surgery, and its cancer is closely linked to the surroundings around the tumor. For a study, researchers used a full single-cell RNA analysis to profile 29,334 cells from iBCC and normal skin next to it for this work. They discovered that iBCC had a lot of active immunity partnerships. To be more specific, SPP1⁺CXCL9/10^high macrophage 1 had strong BAFF signaling with plasma cells, and T follicular helper-like cells had a lot of CXCL13, a chemokine that is found in B cells. 

In the area around the tumor, different types of SPP1⁺CXCL9/10^high macrophages and angiogenesis-related SPP1⁺CCL2^high macrophages were found. Interestingly, they saw more major histocompatibility complex I molecules in fibroblasts in iBCC compared to normal skin next to it. Furthermore, MDK signals from cancerous basal cells were significantly raised, and their expression was a separate factor in predicting the invasion depth of iBCC. It highlighted its role in promoting cancer and changing the environment around the tumor. 

They also found cells that differentiate and are associated with SOSTDC1⁺IGFBP5⁺CTSV⁺ malignant basal subtype 1 and cells that are associated with epithelial−mesenchymal transition and are associated with TNC⁺SFRP1⁺CHGA⁺ malignant basal subtype 2. When there were a lot of cancerous basal 2 cell markers, iBCC cells would invade and come back. Overall, their work helped to explain the different types of cells in iBCC and suggested possible treatment targets for future clinical studies.

Source: sciencedirect.com/science/article/abs/pii/S0022202X23020663